US Drug Recall Register

FDA Drug Recalls

1,739 recalls · Class I, newest first

Class I · High risk Terminated

Adventure First Aid 1.0

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0246-2023
Class I · High risk Terminated

Adventure Marine 150

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0245-2023
Class I · High risk Terminated

Easy Care first aid Burn Cream

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0244-2023
Class I · High risk Terminated

Vancomycin Hydrochloride for Injection

Reason Presence of Particulate Matter: Glass particulate matter detected in injectable.

Pfizer Inc. D-0184-2023
Class I · High risk Terminated

Epinephrine

Reason Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

Spectrum Laboratory Products, Inc. D-0180-2023
Class I · High risk Terminated

Epinephrine

Reason Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

Spectrum Laboratory Products, Inc. D-0179-2023
Class I · High risk Terminated

Advil Liqui Gels

Reason Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0183-2023
Class I · High risk Terminated

Advil Liqui Gels

Reason Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0182-2023
Class I · High risk Terminated

Advil

Reason Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0181-2023
Class I · High risk Terminated

Iohexol

Reason Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL

BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy D-0086-2023
Class I · High risk Terminated

Daptomycin for Injection 350 mg/vial 1 Single-dose vial

Reason Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial

Accord Healthcare, Inc. NDC 16729-0434-05 D-0131-2023
Class I · High risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

Exela Pharma Sciences LLC NDC 72572-740-20 D-0080-2023
Class I · High risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

Exela Pharma Sciences LLC NDC 51754-5001-5 D-0079-2023
Class I · High risk Ongoing

Adam's Polishes ALCOHOL BASED HAND SANITIZER

Reason Chemical Contamination: FDA analysis found 1 lot of Adam's Polishes ALCOHOL BASED HAND SANITIZER isopropyl alcohol 75% v/v to contain methanol.

Adam's Polishes LLC NDC 74943-125-04 D-0066-2023
Class I · High risk Terminated

Octreotide Acetate Injection 500 mcg/mL

Reason Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.

Viatris Inc D-0058-2023
Class I · High risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

Exela Pharma Sciences LLC NDC 72572-740-20 D-0023-2023
Class I · High risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

Exela Pharma Sciences LLC NDC 51754-5001-5 D-0022-2023
Class I · High risk Terminated

Atenolol Tablets

Reason Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets

Golden State Medical Supply Inc. NDC 60429-027-10 D-0019-2023
Class I · High risk Terminated

PROPOFOL Injectable Emulsion

Reason Presence of particulate matter

Pfizer Inc. NDC 0409-4699-54 D-1540-2022
Class I · High risk Terminated

Banana Boat hair & scalp defense

Reason Chemical contamination: presence of benzene

Edgewell Personal Care Brands, LLC D-0212-2024
Class I · High risk Terminated

SANGTER Energy Supplement Capsules

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.

Distributor RFR, LLC. D-1333-2022
Class I · High risk Terminated

Sustango

Reason Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.

Ultra Supplement LLC D-1350-2022
Class I · High risk Terminated

Walgreens

Reason Microbial contamination of non-sterile products.

Vi-Jon, LLC NDC 0363-7162-38 D-1510-2022
Class I · High risk Terminated

Walgreens

Reason Microbial contamination of non-sterile products.

Vi-Jon, LLC NDC 0363-8166-38 D-1509-2022